Skip to main content
. Author manuscript; available in PMC: 2011 Mar 28.
Published in final edited form as: Early Interv Psychiatry. 2010 Aug;4(3):220–226. doi: 10.1111/j.1751-7893.2010.00183.x

Table 5.

Lifetime and Baseline Treatment History in Clinical High Risk Subjects

Baseline Lifetime
Psychotropic
Medication
p Psychosocial
Treatment
p Psychotropic
Medication
p Psychosocial
Treatment
p
Mean(SD) Yes
N=144
No
N=206
Yes
N=172
No
N=141
Yes
N=215
No
N=143
Yes
N=257
No
N=56
Demographics
Age 18.11(4.47) 18.38(4.96) NS 17.42(4.70) 19.54(4.81) <.0.01 18.63(4.49) 17.79(5.05) NS 17.98(4.79) 19.83(4.72) <0.01
Gender (% male) 58.3% 61.7% NS 63.4% 57.4% NS 62.3% 58.7% NS 61.5% 55.2% NS
Ethnicity (% Hispanic) 12.7% 12.8% NS 15.7% 12.8% NS 12.7% 16.9% NS 14.8% 12.5% NS
Education 10.39(3.04) 10.4(3.11) NS 9.78(3.10) 11.18(2.90) <0.01 10.76(3.04) 9.80(2.99) <0.01 10.15(3.09) 11.47(3.10) <0.01
Fam Hx Psychosis 41.0% 46.9% NS 49.6% 38.1% NS 42.0% 49.0% NS 46.5% 36.0% NS
Structured Interview for Prodromal Syndromes
Unusual Thought Content 3.04(1.53) 3.13(1.60) NS 3.09(1.54) 3.04(1.58) NS 3.13(1.55) 3.08(1.59) NS 3.03(1.55) 3.25(1.60) NS
Suspiciousness 2.86(1.57) 2.83(1.46) NS 2.89(1.41) 2.85(1.59) NS 2.91(1.55) 2.78(1.42) NS 2.86(1.46) 2.95(1.63) NS
Grandiosity 1.12(1.34) 1.11(1.38) NS 1.12(1.36) 1.01(1.30) NS 1.15(1.40) 1.06(1.28) NS 1.06(1.27) 1.16(1.59) NS
Hallucinations 2.92(1.72) 2.96(1.75) NS 3.09(1.70) 2.75(1.82) NS 3.05(1.68) 2.83(1.78) NS 2.98(1.73) 2.73(1.89) NS
Disorganized Communication 1.65(1.32) 1.95(1.50) NS 1.95(1.48) 1.63(1.48) NS 1.77(1.39) 2.01(1.51) NS 1.82(1.52) 1.70(1.28) NS
Positive Total 11.60(3.69) 11.97(4.25) NS 12.14(3.79) 11.29(4.33 NS 12.02(3.96) 11.76(4.20) NS 11.76(3.94) 11.79(4.53) NS
Social Anhedonia 2.42(1.82) 2.46(1.99) NS 2.62(1.97) 2.27(1.90) NS 2.48(1.84) 2.46(2.06) NS 2.51(1.94) 2.20(1.86) NS
Avolition 2.42(1.66) 2.25(1.76) NS 2.36(1.71) 2.12(1.69) NS 2.47(1.67) 2.16(1.79) NS 2.29(1.71) 2.20(1.61) NS
Expression of Emotion 1.50(1.56) 1.40(1.60) NS 1.52(1.64) 1.39(1.63) NS 1.48(1.53) 1.48(1.70) NS 1.48(1.62) 1.38(1.71) NS
Experience of Emotion/Self 1.54(1.79) 1.41(1.63) NS 1.33(1.62) 1.43(1.72) NS 1.64(1.81) 1.29(1.52) NS 1.42(1.69) 1.25(1.63) NS
Ideation Richness 1.21(1.42) 1.22(1.50) NS 1.43(1.53) 0.88(1.35) <0.01 1.27(1.46) 1.25(1.53) NS 1.21(1.49) 1.00(1.36) NS
Occupation Functioning 2.85(1.82) 3.21(1.89) NS 3.25(1.74) 2.73(2.02) <0.05 3.05(1.86) 3.12(1.88) NS 3.14(1.82) 2.50(2.19) <0.05
Negative Total 11.80(6.43) 11.94(7.02) NS 12.33(6.46) 10.81(7.05) NS 12.28(6.54) 11.78(7.35) NS 11.91(6.59) 10.52(7.38) NS
Odd Behavior/Appearance 1.35(1.36) 1.41(1.52) NS 1.71(1.45) 1.05(1.38) <0.01 1.35(1.37) 1.49(1.58) NS 1.53(1.46) 0.84(1.28) <0.01
Bizarre Thinking 1.57(1.45) 1.78(1.56) NS 1.96(1.58) 1.42(1.47) <0.01 1.64(1.44) 1.82(1.64) NS 1.86(1.56) 1.09(1.35) <0.01
Trouble w/Focus and Attention 2.46(1.27) 2.48(1.46) NS 2.52(1.42) 2.45(1.40) NS 2.46(1.39) 2.51(1.38) NS 2.50(1.44) 2.45(1.32) NS
Personal Hygiene 0.90(1.28) 0.79(1.22) NS 0.90(1.25) 0.76(1.27) NS 0.91(1.32) 0.77(1.15) NS 0.90(1.27) 0.61(1.20) NS
Disorganized Total 6.29(3.69) 6.44(3.89) NS 7.08(3.83) 5.68(3.91) <0.01 6.36(3.72) 6.59(4.02) NS 6.78(3.86) 4.98)3.83) <0.01
Sleep Disturbance 2.03(1.63) 1.98(1.75) NS 2.13(1.70) 1.83(1.75) NS 2.06(1.69) 1.97(1.73) NS 2.09(1.72) 1.66(1.68) NS
Dysphoric Mood 3.36(1.59) 2.84(1.82) <0.01 3.06(1.68) 2.92(1.83) NS 3.26(1.64) 2.76(1.83) <0.01 3.12(1.69) 2.52(1.89) <0.05
Motor Disturbance 0.75(1.12) 0.68(1.23) NS 0.65(1.14) 0.74(1.18) NS 0.73(1.12) 0.71(1.29) NS 0.65(1.12) 0.91(1.33) NS
Impaired Tolerance to Normal Stress 2.26(1.77) 2.11(1.74) NS 2.26(1.75) 2.11(1.83) NS 2.23(1.79) 2.14(1.72) NS 2.31(1.77) 1.68(1.75) <0.05
General Total 8.40(4.19) 7.59(4.54) NS 8.08(4.27) 7.60(4.64) NS 8.27(4.28) 7.57(4.58) NS 8.16(4.36) 6.77(4.62) <0.05
SIPS Total 37.89(14.74) 38.11(14.74) NS 39.57(13.50) 35.33(15.04) <.0.05 38.77(13.24) 37.96(15.62) NS 38.52(13.88) 34.05(15.62) <0.05
Prodromal Syndrome
Attenuated Positive Symptoms 95.1% 96.6% NS 96.5% 95.7% NS 96.3% 95.8% NS 97.3% 91.1% <0.05
Brief Intermittent Psychotic Symptoms 4.2% 3.9% NS 2.9% 5.0% NS 4.2% 3.5% NS 2.7% 8.9% <0.05
Genetic Risk & Deterioration 8.2% 13.4% NS 13.3% 10.3% NS 9.0% 16.3% <.0.05 13.2% 7.8% NS
Functioning
Premorbid functioning 0.30(0.15) 0.33(0.17) NS 0.26(0.17) 0.33(0.16) NS 0.32(0.16) 0.32(0.16) NS 0.33(0.16) 0.30(0.17) <0.01
GAF 47.23(12.72) 45.92(11.76) NS 43.85(10.15) 50.07(12.99) <0.01 46.53(11.78) 46.35(12.79) NS 44.94(11.12) 53.61(12.73) <0.01
Social Function 6.31(1.42) 6.13(1.54) NS 6.04(1.35) 6.47(1.58) <0.01 6.21(1.37) 6.13(1.66) NS 6.15(1.41) 6.66(1.71) <0.05
Role Function 6.12(1.84) 6.06(1.61) NS 5.99(1.52) 6.49(1.67) <0.01 5.99(1.78) 6.20(1.58) NS 6.12(1.54) 6.59(1.84) <0.05
Psychological Function 5.58(1.07) 5.76(0.85) NS 5.73(0.77) 5.89(0.95) NS 5.6(1.06)* 5.84(0.85) <0.05 5.78(0.83) 5.95(0.98) NS
Comorbid Conditions
Schizotypal Personality Disorder 20.0% 28.6% NS 36.1% 19.4% <0.01 23.9% 29.1% NS 32.4% 9.1% <0.01
Alcohol Use 49.3% 43.6% NS 41.7% 52.2% 0.10 51.5% 36.4% <0.01 44.5% 52.8% NS
Substance Use 41.0% 39.9% NS 35.0% 44.8% 0.10 44.8% 32.6% <0.05 38.1% 42.6% NS
Depression 38.0% 24.2% <.0.01 27.0% 23.2% NS 37.2% 17.9% <0.01 26.5% 20.0% NS
Panic Disorder 10.9% 4.8% <0.05 4.5% 8.1% NS 10.5% 2.2% <0.05 7.0% 4.0% NS
Social Phobia 15.5% 10.3% NS 11.6% 10.5% NS 16.0% 6.5% <0.05 11.4% 10.0% NS